Medline, Inc. MDLN Increase in tax receivable agreement liability
Increase in tax receivable agreement liability at other companies
Other financials
Where this comes from
Reported directly by Medline, Inc. in its filing.
Tagged under the XBRL concept mdln:IncreaseDecreaseInTaxReceivableAgreementLiability.
The source filing: Medline, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0002046386-26-000051
The balance of the TRA liability was $4,404 million and $3,542 million as of June 27, 2026 and December 31, 2025, respectively. As of June 27, 2026, $12 million was included in Accrued expenses and other current liabilities with the remainder in Tax receivable agreement liability on the unaudited Condensed Consolidated Balance Sheets. The Company’s TRA liability increased by $862 million due to the effects of the May 2026 Resale Offering, the March 2026 Resale Offering, and other exchanges of Incentive Units and Common Units during the six months ended June 27, 2026. The Company did not make any payment pursuant to the TRA or record a remeasurement adjustment during the six months ended June 27, 2026.
Item 1 - Financial Statements
FAQ
- What is Medline, Inc.'s increase in tax receivable agreement liability?
- Medline, Inc. (MDLN) reported increase in tax receivable agreement liability of $383M in Q2 2026.
- What does increase in tax receivable agreement liability mean?
- Increase in tax receivable agreement liability as reported by Medline Inc. Class A common stock.
Ask your AI about Medline, Inc.'s increase in tax receivable agreement liability.
Connect your AI assistant and compare it to peers, right in your chat.
